NEW YORK, NY / ACCESSWIRE / December 2, 2019 / The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
The Medicines Company (MDCO)
Merger Announcement: November 24, 2019
Transaction Details: Under the terms of the transaction, Novartis will acquire The Medicines Company for $85 per share in an all-cash transaction.
To learn more about the MDCO investigation and your rights, go to: https://www.zlk.com/mna/the-medicines-company
Gores Holdings III, Inc. (GRSH)
Merger Announcement: November 1, 2019
Transaction Details: Upon closing of the merger, this transaction will introduce PAE as a publicly listed company, and the consideration payable to the stockholders of PAE will consist of a combination of cash and shares of Gores Holdings III common stock.
To learn more about the GRSH investigation and your rights, go to: https://www.zlk.com/mna/gores-holdings-iii-inc
Tiffany & Co. (TIF)
Merger Announcement: November 25, 2019
Transaction Details: Under the terms of the transaction, LVMH will acquire Tiffany for $135 per share in cash.
To learn more about the TIF investigation and your rights, go to: https://www.zlk.com/mna/tiffany-co
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP